Xeris Biopharma Holdings, Inc. XERS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s software and technology licenses, net?
- Xeris Biopharma Holdings, Inc. (XERS) reported software and technology licenses, net of $5.12M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s software and technology licenses, net changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s software and technology licenses, net increased by 0.5% year-over-year, from $5.1M to $5.12M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s software and technology licenses, net has grown at a 86.4% compound annual growth rate (CAGR), from $232K to $5.22M.